Acceptance-Based Coping Skills for Type 2 Diabetes
(ABaCo Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how a phone-based program can help Hispanic/Latino individuals manage type 2 diabetes more effectively. It aims to determine whether sessions with community health workers can improve blood sugar control and overall quality of life. Participants will engage in regular phone calls to learn coping skills (Acceptance Based Coping, or ABaCo) and discuss maintaining personal life values while managing diabetes. This trial suits Hispanic/Latino individuals with type 2 diabetes who struggle with management and already receive care at the study site clinic. As an unphased trial, it offers a unique opportunity to contribute to innovative diabetes management strategies tailored for the Hispanic/Latino community.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It seems likely that you can continue your current diabetes treatments, as the focus is on educational support.
What prior data suggests that this educational intervention is safe for participants?
Research has shown that the Acceptance Based Coping (ABaCo) skills program helps Hispanic/Latino patients with type 2 diabetes improve their quality of life and manage blood sugar levels. Researchers ensure the program's safety by closely monitoring participants during and after the program. They check for any safety concerns and assess the program's effectiveness with evaluations at 24 weeks.
The program includes educational phone calls with community health workers and does not involve medication, typically posing fewer risks than treatments with new drugs. Since the program focuses on support and education, available research has reported no negative effects related to it.
Overall, the ABaCo program appears well-received, aiding individuals in managing their diabetes while staying true to their personal values.12345Why are researchers excited about this trial?
Unlike traditional treatments for Type 2 Diabetes that often focus on medication and dietary changes, Acceptance-Based Coping (ABaCo) is all about helping patients manage stress and emotions related to their condition. This approach is unique because it combines standard diabetes care with specialized skills training delivered over the phone, making it convenient and accessible. Researchers are excited because this method could empower patients to better cope with their diabetes in everyday life, potentially improving both their mental well-being and their ability to manage their condition.
What evidence suggests that the ABaCo program is effective for managing type 2 diabetes?
Research shows that acceptance-based therapies can effectively help manage type 2 diabetes. Studies have found that these therapies lower HbA1c, a measure of blood sugar levels, and improve self-care and quality of life. People with diabetes often benefit more from these therapies than from other methods like mindfulness-based interventions. Additionally, acceptance-based therapies link to better coping strategies and weight management, both crucial for managing diabetes. These findings suggest that the Acceptance Based Coping (ABaCo) program, which participants in this trial will receive, might help control their blood sugar and enhance their overall well-being.678910
Who Is on the Research Team?
Kathryn Kanzler, PsyD ABPP
Principal Investigator
Baylor College of Medicine; UT Health San Antonio
Are You a Good Fit for This Trial?
This trial is for Hispanic/Latino patients with type 2 diabetes. Participants will engage in a program delivered by community health workers over the phone, aimed at improving blood sugar management and quality of life. They must be willing to provide blood samples, answer questionnaires, and commit to weekly calls plus a follow-up.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the ABaCo program through seven individual phone call visits with promotores over 6 weeks, followed by a booster session at week 10.
Follow-up
Participants are monitored for safety and effectiveness after treatment, including final assessments at 24 weeks.
What Are the Treatments Tested in This Trial?
Interventions
- Acceptance Based Coping (ABaCo)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Baylor College of Medicine
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator